Evening Primrose Oil Supplementation Increases Citraturia and Decreases Other Urinary Risk Factors for Calcium Oxalate Urolithiasis

Journal of Urology

Volumn 182, Issue 6, 2009, Pages 2957-2963

  Rodgers, Allen ^a   Lewandowski, Sonja ^a   Allie Hamdulay, Shameez ^a   Pinnock, Diane ^a   Baretta, Gretchen ^a   Gambaro, Giovanni ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

ethnic groups; fatty acids; nephrolithiasis; urinalysis

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CITRIC ACID; PRIMROSE OIL;

ADULT; ARTICLE; CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CAUCASIAN; CITRATURIA; CONTROLLED STUDY; DIETARY INTAKE; ETHNICITY; HUMAN; MALE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; URINALYSIS; URINE LEVEL;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CALCIUM OXALATE; CITRATES; DIETARY SUPPLEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GAMMA-LINOLENIC ACID; HUMANS; LINOLEIC ACIDS; MALE; PLANT OILS; RISK FACTORS; UROLITHIASIS; YOUNG ADULT;

EID: 72149097855     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.021     Document Type: Article

References (29)

1. Modlin M. Urinary sodium and renal stone. In: Hodgkinson A., and Nordin B.E.C. (Eds). Renal Stone Research Symposium (1968), J, London, United Kingdom 209-220
2. Sinclair H. The relative importance of essential fatty acids of the linoleic and linolenic families: studies with an Eskimo diet. Prog Lipid Res 20 (1981) 897
3. Buck A.C. Is marine oil and evening primrose oil the treatment for nephrolithiasis?. In: Tiselius H.G. (Ed). Renal Stones (1996), Akademitryck, Edsbruk 49-57
4. Buck A.C., Davies R.L., and Harrison T. The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrolithiasis. J Urol 146 (1991) 188
5. Buck A.C., Lote C.J., and Sampson W.F. The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 129 (1983) 421
6. Henriquez-La Roche C., Rodriguez-Iturbe B., and Parra G. Increased urinary excretion of prostaglandin E2 in patients with idiopathic hypercalciuria is a primary phenomenon. Clin Sci 83 (1992) 75
7. Baggio B., Gambaro G., Zambon S., et al. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol 7 (1996) 613
8. Messa P., Londero D., Massarino F., et al. Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers. Nephrol Dial Transplant 15 (2000) 1388
9. Baggio B., Budakovic A., Nassuato M., et al. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 58 (2000) 1278
10. Tulloch I., Smellie W., and Buck A.C. Evening primrose oil reduces urinary calcium excretion in both normal and hypercalciuric rats. Urol Res 22 (1994) 227
11. Burgess N.A., Reynolds T.M., Williams N., et al. Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. Urol Res 23 (1995) 239
12. Rodgers A.L., and Lewandowski S. Effects of 5 different diets on urinary risk factors for calcium oxalate kidney stone formation: evidence of different renal handling mechanisms in different race groups. J Urol 168 (2002) 931
13. Lewandowski S., and Rodgers A.L. Renal response to lithogenic and anti-lithogenic supplement challenges in a stone-free population group. J Ren Nutr 14 (2004) 170
14. Tiselius H.G. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 122 (1982) 409
15. Laube N., Hergarten S., Hoppe B., et al. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas. J Urol 172 (2004) 355
16. Rothwell P.J., Green R., Blacklock N.J., et al. Does fish oil benefit stone formers?. J Urol 150 (1993) 1391
17. Inoue K., Zhuang L., Maddox D.M., et al. Structure, function and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J Biol Chem 277 (2002) 39469
18. Zara V., Giudetti A.M., Siculella L., et al. Covariance of tricarboxylate carrier activity and lipogenesis in liver of polyunsaturated fatty acid (n-6) fed rats. Eur J Biochem 268 (2001) 5734
19. Siculella L., Sabetta S., Damiano F., et al. Different dietary fatty acids have dissimilar effects on activity and gene expression of mitochondrial tricarboxylate carrier in rat liver. FEBS Lett 578 (2004) 280
20. Xiang M., Rahman M.A., Ai H., et al. Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab 50 (2006) 492
21. Biagi P.L., Bordini A., Hrelia S., et al. Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta-6-desaturase activity. Biochim Biophys Acta 1083 (1991) 187
22. Gambaro G., Bordoni A., Hrelia S., et al. Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insight in calcium lipogenesis. J Lab Clin Med 135 (2000) 89
23. Baggio B., Budakovic A., and Priante G. Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Nephron 91 (2002) 486
24. Brenner R.R. Factors influencing fatty acid chain elongation and desaturation. In: Vergroesen A.J., and Crawford M. (Eds). The Role of Fats in Human Nutrition. 2nd ed. (1989), Academic Press, London: United Kingdom 45-79
25. Naya Y., Ito H., Masai M., et al. Association of dietary fatty acids with urinary oxalate excretion in calcium oxalate stone-formers in their fourth decade. BJU Int 89 (2002) 842
26. Selvam R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30 (2002) 35
27. Anbazhagan M., Hariprasad C., Samufram P., et al. Effect of oral supplementation of vitamin E on urinary risk factors in patients with hyperoxaluria. J Clin Biochem Nutr 27 (2000) 37
28. Dirks J.H. Hypo-hypermagnasaemia. In: Davison A.M., Cameron J.S., Grunfeld J.P., et al. (Eds). Oxford Textbook of Clinical Nephrology. 3rd ed. (2004), Oxford University Press, Oxford 309-339
29. Taylor E.N., Stampfer M.J., and Curhan G.C. Fatty acid intake and incidence of nephrolithiasis. Am J Kidney Dis 45 (2005) 267